TerminatedPhase 2NCT01261624

Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Italfarmaco
Principal Investigator
Francesco Zulian, MD
Azienda Ospedaliera-Università di Padova - Unità di Reumatologia Pediatrica
Intervention
Givinostat(drug)
Enrollment
16 enrolled
Eligibility
2-17 years · All sexes
Timeline
20102013

Study locations (13)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01261624 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials